3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow sevirumab: new trials by email Literature Review of sevirumab trials Research Report on sevirumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease SDZ MSL-109 - Cytomegalovirus Infections | Phase 1 / Phase 2 | Completed | National Center for Research Resources (NCRR) | 1995-02-01 | 2005-06-24 | |
| A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria Sevirumab - Cytomegalovirus Infections, HIV Infections | Phase 1 | Completed | Sandoz | 2005-06-24 | ||
| A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis Sevirumab - Cytomegalovirus Retinitis, HIV Infections | Phase 1 | Completed | Sandoz | 2005-06-24 |
Cytomegalovirus Infections (3) · HIV Infections (2) · AIDS-Related Opportunistic Infections (1) · Acquired Immunodeficiency Syndrome (1) · Communicable Diseases (1) · Cytomegalovirus Retinitis (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Infant, Newborn, Diseases (1) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1) · Rare Diseases (1) · Retinitis (1) · Virus Diseases (1)
Sandoz (2) · National Center for Research Resources (NCRR) (1)
United States (2)